CASE REPORTS Patient 1. This patient was aged 20 years when first seen on November 29, 1971, because of secondary amenorrhoea. Since her menarche at age 19 years, she had had only one menstrual period (February, 1971) . Clinical examination was normal except for hirsutes on the thighs and upper arms and poor breast development. The uterus was small, mobile, and anteverted. Skull X-rays, adrenal steroid excretion and thyroid function tests were normal.
Treatment by clomiphene, 50 mgms. daily for five days was commenced on March 27, 1973. A pregnancy test was positive on May 14, 1973. At examination on May 21, 1973 and on June 8, 1973 the size of the uterus corresponded to six weeks and eight weeks gestation respectively. From July 1973, the size of the uterus 'was always in excess of the period of amenorrhoea. On October 12, 1973 , the size of the uterus corresponded to 32 weeks, whereas the interval since ovulation was 26 weeks. An ultrasonic scan confirmed gross polyhydramnios and the absence of a fetal skull. A transabdominal amniocentesis was carried out; the amniotic fluid alpha-fetoprotein level was 43.0 sg/ml. At 26 weeks gestation the mean amniotic fluid alpha-fetoprotein level is 3.15 Lg/ml; and the 95th percentile 5.82 ,ug/ml (Nevin, Thompson & Nesbitt, 1974 
DISCUSSION
The use of ovulation stimulation agents such as clomiphene in the management of infertility has become widespread. Until recently, the only problems encountered in the use of clomiphene has been the high incidence of multiple pregnancy, and a high rate of early abortion (Whitelaw, et al, 1970; Murray, et al, 1971; Hack, et al 1972) . Within the past few years, it has been suggested that clomiphene may have a teratogenic action (Table) . In 1973, Dyson and Kohler, described two patients who produced infants with anencephaly and spina bifida following treatment with clomiphene. Since this initial report, several similar observations have been reported (Sandler, 1973; Barrett & Hakim, 1973; Field & Kerr, 1974) . To date there have been six patients on clomiphene who had infants with a neural tube defect (Table) .
The present paper describes four women receiving clomiphene who produced five infants with a neural tube defect; two had anencephaly and/or spina bifida; of the remaining three cases one had iniencephaly; another microcephaly and an encephalocele, and the fifth microcephaly, frontal encephalocele and meningomyelocoele.
Interestingly, although clomiphene has been used extensively in the United States, there are no published reports suggesting a casual association of neural tube defects and clomiphene. However, several large series of women receiving ovulation stimulation agents for a variety of causes of infertility have been reported but without any indication of an increased incidence of neural tube defects or indeed any congenital abnormality among their offspring. Goldfarb, et al (1968) found no increase in the incidence of congenital abnormalities in the offspring of women on clomiphene. In 166 infants and 17 abortuses in their study, only two congenital abnormalities, both haemangiomas, were noted. In the series reported by Whitelaw, et al (1970) of 88 pregnancies which resulted in 67 livebirths, there was no mention of congenital abnormalities. However, of the 104 infants born to 86 women on clomiphene reported by Hack, et al (1972) , six had congenital abnormalities. One infant had a double aorta, hypoplasia of the right arch and a preductile coarctation of left arch with a patent ductus arteriosus; another infant had absence of second and fifth 62 Sandler (I 973) 1 Primigravida digits; two additional infants had congenital dislocation of the hip; and another two had pyloric stenosis. None of the 104 infants had neural tube defects. Although they concluded that the "incidence of congenital malformations did not differ significantly from that found in the general population", six of 104 infants with a congenital abnormality should not be dismissed lightly.
An alternate explanation for the association of anencephaly and clomiphene is that couples who have infants with neural tube defects are subfertile and, therefore, likely to receive ovulation stimulation agents (Dyson & Kohler, 1973; James, 1973 James, , 1974 . Several epidemiological surveys of anencephaly have shown a longer fallow interval or conception wait before the anencephalic birth than in controlled groups (Smithells, et al, 1964; James, 1974) . James (1974) using the data of the British Perinatal Mortality Survey (1963) and taking only patients with no previous obstetric history showed the following: of 134 cases of anencephaly, in 74 cases the marriage to confinement interval exceeded the median of the distribution of the control group. He concluded that although this finding was not statistically significant, it did suggest that primiparous mothers of anencephalic infants have a longer marriage to conception interval. As there is an association between dizygotic twinning (due to double ovulation) and anencephaly, Elwood (1974) has suggested that perhaps clomiphene acts via a mechanism which increases the risk of both.
Couples who produce infants with anencephaly may be subfertile, not because they are less able to conceive, but because they have a high spontaneous abortion rate (Record & McKeown, 1950; Coffey & Jessop, 1958; James, 1974) . Thus, among their pregnancies there is a higher proportion of recognised and unrecognised spontaneous abortion.
There is undoubtedly a need for more information on the relationship between fertility and neural tube defects. A prospective survey of women receiving clomiphene is being carried out and a complete ascertainment of families with an infant with a neural tube defect born 1971-1974 inclusive, has been undertaken to determine some of the parameters of fertility. However, it is also important not to ignore the possible teratogenic effect of clomiphene. SUMMARY This paper describes four patients who had five infants with neural tube defects while receiving clomiphene for infertility. Of the five infants two had anencephaly and/or spina bifida; one had iniencephaly; another, microcephaly and an encephalocele; and the fifth, microcephaly, a frontal encephalocele and a meningomyelocele. The possible teratogenic effect of clomiphene is discussed but it is also suggested that anencephalic-prone-couples are subfertile and thus anencephalic births would be associated, but not casually, with the administration of drugs designed to alleviate infertility.
